Table 1.
Clinical characteristic of the hepatocellular carcinoma patients
| Patient ID | Age | Sex | Pathological type | Size of tumor | BCLC stage | HBsAg (IU/mL) | HBV-DNA (IU/mL) | AFP (ng/mL) | ALT(U/L) | AST(U/L) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 58 | M | Moderately differentiated | 32 × 22 mm | A | > 180 | 8.69E+3 | 1073 | 40.7 | 33.3 |
| 2 | 47 | M | Poorly differentiated | 28 × 25 mm | A | 29.86 | 1.06E+2 | 1.43 | 248.2 | 183.2 |
| 3 | 64 | M | Moderately differentiated | 77 × 71 mm | B | > 180 | 1.08E+5 | 110 | 25.8 | 55.1 |
| 4 | 60 | M | Moderately to poorly differentiated | 106 × 73 mm | C | 159.58 | 3.24E+2 | 16.09 | 33.6 | 46 |
| 5 | 61 | M | Moderately differentiated | 16 × 17 mm | O | > 250 | 5.89E+2 | 766.5 | 16 | 12.9 |
| 6 | 46 | M | Moderately to poorly differentiated | 27 × 28 mm | A | > 180 | 2.60E+5 | 4371 | 37.2 | 25.7 |
| 7 | 38 | M | Moderately differentiated | 25 × 24 mm | A | 251.9 | < 100 | 0.746 | 35 | 43 |
| 8 | 76 | M |
S8:Well-differentiated S7:Moderately to poorly differentiated |
15 × 13 mm | O | 1.17 | < 100 | unknown | 28 | 28 |
| 9 | 57 | M | Moderately differentiated | 27 × 19 mm | A | > 250 | 5.05E+03 | 3.129 | 20 | 16 |
| 10 | 64 | M | Well-differentiated | 24 × 20 mm | A | 2165 | < 100 | 5.06 | 24 | 22 |
| 11 | 53 | M | Moderately differentiated | 62 × 63 mm | B | 1070 | 4.21E+05 | 3.516 | 32 | 53 |
| 12 | 45 | M | Moderately differentiated | 81 × 51 mm | B | > 180 | 1.21E+2 | 855.5 | 23.5 | 19.2 |